{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T13:55:58Z","timestamp":1771336558219,"version":"3.50.1"},"reference-count":22,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"Radiological Society of North America","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["redjournal.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.ijrobp.2018.06.031","type":"journal-article","created":{"date-parts":[[2018,6,27]],"date-time":"2018-06-27T22:36:14Z","timestamp":1530138974000},"page":"1029-1035","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Significance of Negative Posttreatment 18-FDG PET\/CT Imaging in Patients With p16\/HPV-Positive Oropharyngeal Cancer"],"prefix":"10.1016","volume":"102","author":[{"given":"Sweet Ping","family":"Ng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason M.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. Brandon","family":"Gunn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David I.","family":"Rosenthal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heath D.","family":"Skinner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jack","family":"Phan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven J.","family":"Frank","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Morrison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erich M.","family":"Sturgis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank E.","family":"Mott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle D.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clifton D.","family":"Fuller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam S.","family":"Garden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2018.06.031_bib1","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/jnci\/djn025","article-title":"Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers","volume":"100","author":"Gillison","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijrobp.2018.06.031_bib2","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1200\/JCO.2015.61.6995","article-title":"Epidemiology of human papillomavirus-positive head and neck squamous cell carcinoma","volume":"33","author":"Gillison","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2018.06.031_bib3","doi-asserted-by":"crossref","first-page":"4550","DOI":"10.1200\/JCO.2013.50.3870","article-title":"Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers","volume":"31","author":"Chaturvedi","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2018.06.031_bib4","doi-asserted-by":"crossref","first-page":"E1030","DOI":"10.1503\/cmaj.161379","article-title":"Human papillomavirus in oropharyngeal cancer in Canada: Analysis of 5 comprehensive cancer centres using multiple imputation","volume":"189","author":"Habbous","year":"2017","journal-title":"CMAJ"},{"key":"10.1016\/j.ijrobp.2018.06.031_bib5","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1056\/NEJMoa0912217","article-title":"Human papillomavirus and survival of patients with oropharyngeal cancer","volume":"363","author":"Ang","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2018.06.031_bib6","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/jnci\/djn011","article-title":"Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial","volume":"100","author":"Fakhry","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijrobp.2018.06.031_bib7","doi-asserted-by":"crossref","first-page":"3858","DOI":"10.1200\/JCO.2014.55.3925","article-title":"Randomized phase III trial to test accelerated versus standard fractionation in combination with concurrent cisplatin for head and neck carcinomas in the radiation therapy oncology group 0129 trial: Long-term report of efficacy and toxicity","volume":"32","author":"Nguyen-Tan","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2018.06.031_bib8","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.oraloncology.2013.12.003","article-title":"Reliability of post-chemoradiotherapy F-18-FDG PET\/CT for prediction of locoregional failure in human papillomavirus-associated oropharyngeal cancer","volume":"50","author":"Vainshtein","year":"2014","journal-title":"Oral Oncol"},{"key":"10.1016\/j.ijrobp.2018.06.031_bib9","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1200\/JCO.2014.55.1937","article-title":"Human papillomavirus and overall survival after progression of oropharyngeal squamous cell carcinoma","volume":"32","author":"Fakhry","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2018.06.031_bib10","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/cncr.29782","article-title":"Determining optimal follow-up in the management of human papillomavirus-positive oropharyngeal cancer","volume":"122","author":"Frakes","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2018.06.031_bib11","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1002\/lary.25985","article-title":"Challenges in establishing the diagnosis of human papillomavirus-related oropharyngeal carcinoma","volume":"126","author":"Truong Lam","year":"2016","journal-title":"Laryngoscope"},{"key":"10.1016\/j.ijrobp.2018.06.031_bib12","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.2967\/jnumed.113.136796","article-title":"Head and neck PET\/CT: Therapy response interpretation criteria (Hopkins criteria)-interreader reliability, accuracy, and survival outcomes","volume":"55","author":"Marcus","year":"2014","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ijrobp.2018.06.031_bib13","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1002\/hed.23434","article-title":"Outcomes after primary chemoradiotherapy for N3 (>6 cm) head and neck squamous cell carcinoma after an FDG-PET\u2013guided neck management policy","volume":"36","author":"Adams","year":"2014","journal-title":"Head Neck"},{"key":"10.1016\/j.ijrobp.2018.06.031_bib14","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1056\/NEJMoa1514493","article-title":"PET-CT surveillance versus neck dissection in advanced head and neck cancer","volume":"374","author":"Mehanna","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2018.06.031_bib15","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/hed.20130","article-title":"Utility of positron emission tomography for the detection of disease in residual neck nodes after (chemo)radiotherapy in head and neck cancer","volume":"27","author":"Porceddu","year":"2005","journal-title":"Head Neck"},{"key":"10.1016\/j.ijrobp.2018.06.031_bib16","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1007\/s10147-015-0936-y","article-title":"Imaging strategy for response evaluation to chemoradiotherapy of the nodal disease in patients with head and neck squamous cell carcinoma","volume":"21","author":"Nishimura","year":"2016","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2018.06.031_bib17","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ijrobp.2008.07.019","article-title":"Clinical significance of postradiotherapy [18F]-fluorodeoxyglucose positron emission tomography imaging in management of head-and-neck cancer\u2014a long-term outcome report","volume":"74","author":"Yao","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2018.06.031_bib18","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1002\/lary.24617","article-title":"Predictive accuracy of first post-treatment PET\/CT in HPV-related oropharyngeal squamous cell carcinoma","volume":"124","author":"Koshkareva","year":"2014","journal-title":"Laryngoscope"},{"key":"10.1016\/j.ijrobp.2018.06.031_bib19","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.3174\/ajnr.A3494","article-title":"Negative predictive value of surveillance PET\/CT in head and neck squamous cell cancer","volume":"34","author":"McDermott","year":"2013","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.ijrobp.2018.06.031_bib20","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1007\/s00259-015-3290-4","article-title":"18)F-FDG PET\/CT to assess response and guide risk-stratified follow-up after chemoradiotherapy for oropharyngeal squamous cell carcinoma","volume":"43","author":"Bird","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.ijrobp.2018.06.031_bib21","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.rpor.2011.04.007","article-title":"Comparison of positron emission tomography\/computed tomography imaging and ultrasound in surveillance of head and neck cancer\u2014the 3-year experience of the ENT department in Poznan","volume":"16","author":"Wierzbicka","year":"2011","journal-title":"Rep Pract Oncol Radiother"},{"key":"10.1016\/j.ijrobp.2018.06.031_bib22","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1016\/j.jcms.2014.06.023","article-title":"Planned neck dissection after chemoradiotherapy in advanced oropharyngeal squamous cell cancer: The role of US, MRI and FDG-PET\/TC scans to assess residual neck disease","volume":"42","author":"Pellini","year":"2014","journal-title":"J Craniomaxillofac Surg"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301618310228?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301618310228?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,5]],"date-time":"2018-12-05T12:45:00Z","timestamp":1544013900000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301618310228"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S0360301618310228"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2018.06.031","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Significance of Negative Posttreatment 18-FDG PET\/CT Imaging in Patients With p16\/HPV-Positive Oropharyngeal Cancer","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2018.06.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}